MedPath

Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery

Phase 3
Completed
Conditions
Perioperative Hemodynamic Optimization
Cardiac Surgery
Interventions
Other: Goal-directed Resuscitation Therapy (GDT)
Other: Standard protocol
Registration Number
NCT01470976
Lead Sponsor
University of Sao Paulo
Brief Summary

The primary aim of the study is to investigate whether a goal-directed resuscitation therapy in high-risk patients through cardiac index optimization using the LiDCO Rapid device reduces complications after cardiac surgery. The hypothesis is that there are better outcomes when achieving a cardiac index higher than 3L/min/m2 in those patients with an arterial lactate higher than 1.5 mmol/L.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • All elective primary and redo adult cardiac surgical patients for coronary artery bypass grafting, valve procedure or combined procedures

  • Adults patients

  • Written informed consent

  • One of the following criteria:

    • EuroSCORE (European System for Cardiac Operative Risk Evaluation) higher than or equal to 6
    • Ejection fraction lower than 50%
    • Recent myocardial infarction
    • Unstable angina
Read More
Exclusion Criteria
  • Age less than 18 years
  • Infectious endocarditis
  • Transplant procedures
  • Emergency procedures
  • Pulmonary hypertension
  • Preoperative cardiogenic shock or use of dobutamine
  • Congenital procedures
  • Need for intra-aortic balloon pump (IABP)
  • Noradrenaline dose higher than 1mcg/kg/min
  • Pregnancy
  • Patients who refused participation in the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Goal-directed Therapy (GDT) ProtocolGoal-directed Resuscitation Therapy (GDT)-
Standard ProtocolStandard protocol-
Primary Outcome Measures
NameTimeMethod
Composite of death or major postoperative complicationswithin 30 days after cardiac surgery

Death or one of the following complications: stroke, renal failure, respiratory complications, cardiovascular complications, deep wound infection and reoperation for any reason.

Secondary Outcome Measures
NameTimeMethod
Fluid balanceduring ICU stay

To compare fluid balance during ICU stay between groups.

Mechanical ventilationwithin 30 days after cardiac surgery

To compare the number of mechanical ventilation free-days between groups.

Cardiovascular measureswithin 30 days after cardiac surgery

To compare levels of BNP, myocardial enzymes, echocardiographic measures and free-days of vasopressors and inotropes between groups.

Duration of ICU stay and hospital stay.within 30 days after cardiac surgery

To compare the number of days of ICU stay and hospital stay between groups.

Tissue hypoperfusion markerswithin 30 days after cardiac surgery

To compare levels of DO2, lactate, ScvO2, base excess and venous to arterial carbon dioxide difference between groups.

Trial Locations

Locations (1)

Instituto do Coracao - InCor / HCFMUSP

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath